EFFECTS OF A NEW "CORONARY VASODILATOR" ON THE GENERAL AND CORONARY HEMODYNAMICS AND MYOCARDIAL METABOLISM OF MAN
Authors: E TRAKS, D B HACKEL, S M SANCETTA
Journal: Annals of Internal Medicine (1959)

Article1 July 1959EFFECTS OF A NEW "CORONARY VASODILATOR" ON THE GENERAL AND CORONARY HEMODYNAMICS AND MYOCARDIAL METABOLISM OF MANELMERICE TRAKS, M.D., DONALD B. HACKEL, M.D., SALVATORE M. SANCETTA, M.D., F.A.C.P.ELMERICE TRAKS, M.D.Search for more papers by this author, DONALD B. HACKEL, M.D.Search for more papers by this author, SALVATORE M. SANCETTA, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-51-1-31 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe continued pharmacologic search for drugs capable of producing a positive increase in the coronary blood of man is an important phase in the management of patients with coronary artery disease. It is a distressing fact that many substances which pharmacologically appear to be promising later fail to fulfill this promise in the course of direct clinical trial. The clinical use of such "vasodilator" substances is often predicated upon the physiologic observation that they produce an increased coronary blood flow in animal preparations, without considering the possibility that the increase in flow may represent solely a heightened myocardial demand induced...Bibliography1. AhlquistHobentachWoodbury RPBRA: A pharmacologic study of N-methyl-N-cinnamyl-2-phenyl-propylamine, J. Am. Pharm. A. (Scient. Ed.) 38: 425, 1949. CrossrefGoogle Scholar2. BarkerSummerson SBWH: The colorimetric determination of lactic acid in biological material, J. Biol. Chem. 138: 535, 1948. CrossrefGoogle Scholar3. DaviesBrink PWF: Microelectrodes for measuring oxygen tension in animal tissues, Rev. Scient. Instruments 13: 524, 1942. CrossrefGoogle Scholar4. EckenhoffHafkenschiel JEJH: The effect of nikethamide on coronary blood flow and cardiac oxygen metabolism, J. Pharmacol. and Exper. Therap. 91: 362, 1947. MedlineGoogle Scholar5. EckenhoffHafkenschielLandmesser JEJHCM: The coronary circulation in the dog, Am. J. Physiol. 148: 582, 1947. CrossrefMedlineGoogle Scholar6. EckenhoffHafkenschielLandmesserHarmel JEJHCMM: Cardiac oxygen metabolism and control of the coronary circulation, Am. J. Physiol. 149: 634, 1947. CrossrefMedlineGoogle Scholar7. FoltzRubinSteigerGazes ELAWADC: The effects of intravenous aminophylline upon the coronary blood-oxygen exchange, Circulation 2: 215, 1950. CrossrefMedlineGoogle Scholar8. FriedemannHaugen TEGE: Pyruvic acid determination of keto acids in blood and urine, J. Biol. Chem. 147: 415, 1943. CrossrefGoogle Scholar9. GoodaleHackel WTDB: Measurement of coronary blood flow in dogs and man from rate of myocardial nitrous oxide desaturation, Circul. Res. 1: 502, 1953. CrossrefMedlineGoogle Scholar10. GoodaleLubinEckenhoffHafkenschielBanfield WTHJEJHWG: Coronary sinus catheterization for studying coronary blood flow and myocardial metabolism, Am. J. Physiol. 152: 340, 1948. CrossrefMedlineGoogle Scholar11. KienGomollSherrod GAAWTR: Coronary vasodilator action of cinnamyl vonedrine, Federation Proc. 15: 446, 1956. Google Scholar12. SilberKatz ENLN: Coronary dilators and angina. Reappraisal, J. A. M. A. 153: 1075, 1953. CrossrefMedlineGoogle Scholar13. Somogyi M: Determination of blood sugar, J. Biol. Chem. 160: 69, 1945. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Cleveland, Ohio*Received for publication September 15, 1958.From the Departments of Medicine and Pathology, Cleveland Metropolitan General Hospital and Western Reserve University, Cleveland, Ohio.†With the technical assistance of GLADYS HECKMAN, R. N., HANNA JANOUSKOVEC, R. N., and EDNA STONE, A. B., Cleveland, Ohio.Supported by grants from the U. S. Public Health Service (H-863) (Dr. Hackel), The William S. Merrell Co., and the Cleveland Area Heart Society (Dr. Sancetta), and performed in part during tenure of a Research Fellowship from the American Heart Association (Dr. Traks).‡Vasoflex is the trademark of the Wm. S. Merrell Co., Cincinnati, Ohio. It was supplied as a parenteral solution containing 5 mg./ml.Requests for reprints should be addressed to Elmerice Traks, M.D., Cleveland Metropolitan General Hospital, 3395 Scranton Road, Cleveland 9, Ohio. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited bySYMPATHOMIMETIC DRUGSIsoproterenol and cardiovascular performancePROBLEMS IN THE TREATMENT OF DECOMPRESSION SICKNESS (AND TRAUMATIC AIR EMBOLISM)Bibliography 1 July 1959Volume 51, Issue 1Page: 31-38KeywordsClinical trialsCoronary arteriesDrugsFellowshipsHeartHemodynamicsHospital medicineMedical servicesStable coronary artery diseaseVasodilators ePublished: 1 December 2008 Issue Published: 1 July 1959 PDF downloadLoading ...